FRIDAY, Nov. 19, 2021 (HealthDay News) — Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is aContinue Reading

FRIDAY, Nov. 16, 2021 (HealthDay News) — Low-dose aspirin neither reduces nor increases the risk of dementia in adults with type 2 diabetes, a new study finds. “This is reassuring that an increase in the risk of dementia is unlikely for the millions of people worldwide who regularly take aspirinContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease,Continue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Nearly a third of health care staff in U.S. hospitals were not vaccinated against COVID-19 as of mid-September, a new study shows. Researchers analyzed data on more than 3.3 million health care workers at more than 2,000 hospitals nationwide between Jan. 20 andContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Vaccinated health care workers with breakthrough COVID-19 infections shed less virus than those who are unvaccinated and infected, according to University of California, Los Angeles researchers. “SARS-CoV-2 viral loads are known to be a critical driver of transmission,” wrote authors led by Dr.Continue Reading